GW Pharmaceuticals PLC Director/PDMR Shareholding (0994A)
December 17 2014 - 10:49AM
UK Regulatory
TIDMGWP
RNS Number : 0994A
GW Pharmaceuticals PLC
17 December 2014
GW Pharmaceuticals PLC Director/PDMR Shareholding
17 December 2014
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the
"Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Porton Down, UK, 17 December 2014: GW Pharmaceuticals (AIM: GWP)
hereby provides notification that the Company has today been
notified that earlier in the day Mr Justin Gover, Chief Executive
Officer of the Company, and his wife have completed a transfer of
the ownership of 2,143,314 0.1 pence ordinary shares of GW
Pharmaceuticals plc to The Gover Family Investment LLP, an
investment vehicle in which they jointly retain a 100%
interest.
This transfer, representing 0.9% of the Company's current issued
share capital, took place for nil consideration and was completed
when the market price of the Company's ordinary shares was 353
pence per share.
Following this notification Mr Gover's beneficial interest in GW
Pharmaceuticals plc ordinary shares of 0.1 pence each remains
unchanged at 2,143,315 shares, representing 0.9% of the Company's
current issued share capital.
The total number of shares outstanding in the Company is
236,800,996 ordinary shares of 0.1 pence each.
Enquiries:
GW Pharmaceuticals PLC Tel: +44 (0)1980 557 000
Adam George, Company Secretary
Peel Hunt LLP (Nominated Adviser) Tel: +44 (0)207 418 8900
James Steel/Claire Terlouw
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFSRFDLDLIS
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024